Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Batist

Showing results (101-110 of 165) with videos related to

Pageof 17
Sort By:
Oncogene|July 2, 2004
Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cellsAla-Eddin Al Moustafa, William D Foulkes, Annick Wong, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 31, 2008
Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot studyFrederique Retornaz, Johanne Monette, Gerald Batist, et al.
Cancer Cell International|August 11, 2020
Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patientsHamda Al-Thawadi, Ishita Gupta, Ayesha Jabeen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2017
Substantial Toxic Effect of Water-Pipe Smoking on the Early Stage of Embryonic DevelopmentAnas A Ashour, Mahmoud Y Haik, Khaled W Sadek, et al.
The Patient|July 29, 2025
Patient Preferences for Metastatic Colorectal Cancer Treatment: A Multi-method Approach Using Discrete Choice Experiments and Best-Worst ScalingCarina Oedingen, Karen V MacDonald, Barry D Stein, et al.
Cancer Research Communications|July 2, 2024
mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered TumorsConstance A Sobsey, Bjoern C Froehlich, Georgia Mitsa, et al.
Anti-Cancer Drugs|March 14, 2003
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancerChristine E Swenson, Lois E Bolcsak, Gerald Batist, et al.
Frontiers in Pharmacology|May 16, 2013
Systemic cancer therapy: achievements and challenges that lie aheadMichael O Palumbo, Petr Kavan, Wilson H Miller, et al.
Analytical Chemistry|August 31, 2017
Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and TumorsRobert Popp, Huiyan Li, André LeBlanc, et al.
Gynecologic Oncology|September 10, 2002
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapyMichael V Seiden, Kenneth D Swenerton, Ursula Matulonis, et al.
Pageof 17

Showing results (101-110 of 165) with videos related to

Sort By:
Pageof 17
Oncogene|July 2, 2004
Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cellsAla-Eddin Al Moustafa, William D Foulkes, Annick Wong, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 31, 2008
Usefulness of frailty markers in the assessment of the health and functional status of older cancer patients referred for chemotherapy: a pilot studyFrederique Retornaz, Johanne Monette, Gerald Batist, et al.
Cancer Cell International|August 11, 2020
Co-presence of human papillomaviruses and Epstein-Barr virus is linked with advanced tumor stage: a tissue microarray study in head and neck cancer patientsHamda Al-Thawadi, Ishita Gupta, Ayesha Jabeen, et al.
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|June 13, 2017
Substantial Toxic Effect of Water-Pipe Smoking on the Early Stage of Embryonic DevelopmentAnas A Ashour, Mahmoud Y Haik, Khaled W Sadek, et al.
The Patient|July 29, 2025
Patient Preferences for Metastatic Colorectal Cancer Treatment: A Multi-method Approach Using Discrete Choice Experiments and Best-Worst ScalingCarina Oedingen, Karen V MacDonald, Barry D Stein, et al.
Cancer Research Communications|July 2, 2024
mTORC1-Driven Protein Translation Correlates with Clinical Benefit of Capivasertib within a Genetically Preselected Cohort of PIK3CA-Altered TumorsConstance A Sobsey, Bjoern C Froehlich, Georgia Mitsa, et al.
Anti-Cancer Drugs|March 14, 2003
Pharmacokinetics of doxorubicin administered i.v. as Myocet (TLC D-99; liposome-encapsulated doxorubicin citrate) compared with conventional doxorubicin when given in combination with cyclophosphamide in patients with metastatic breast cancerChristine E Swenson, Lois E Bolcsak, Gerald Batist, et al.
Frontiers in Pharmacology|May 16, 2013
Systemic cancer therapy: achievements and challenges that lie aheadMichael O Palumbo, Petr Kavan, Wilson H Miller, et al.
Analytical Chemistry|August 31, 2017
Immuno-Matrix-Assisted Laser Desorption/Ionization Assays for Quantifying AKT1 and AKT2 in Breast and Colorectal Cancer Cell Lines and TumorsRobert Popp, Huiyan Li, André LeBlanc, et al.
Gynecologic Oncology|September 10, 2002
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapyMichael V Seiden, Kenneth D Swenerton, Ursula Matulonis, et al.
Pageof 17